RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$22.64
-18.01%
Mkt Cap $1.24B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (16 analysts)
$67.00
Range $52.00 – $80.00
Implied Upside
+195.9%
Consensus $67.00 vs current $22.64